US Patent 8410264 Heterocyclic oxime compounds
Patent 8410264 was granted and assigned to Novartis on April, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+83 characters)
Article
Patent abstract
The invention relates to compounds of formula (I) and salts thereof:
Edits on 5 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+13 properties)
Infobox
Patent Inventor Names
Fang Liang0
Feng He0
Guoliang Xun0
Ji Yue Zhang0
Lei Jiang0
Lei Liu0
Miao Dai0
Xiaoxia Yan0
Xingnian Fu0
Yao-chang Xu0
Yuan Mi0
Yue Li0
Zhengtian Yu0
Edits on 13 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 17 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08410264 Heterocyclic oxime compounds US Patent 8410264 Heterocyclic oxime compounds
Infobox
Patent Number
08410264
Patent Number
8410264
Edits on 16 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08410264 Heterocyclic oxime compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08410264
Date of patent
April 2, 2013
Patent application number
12859653
Date Filed
August 19, 2010
Patent primary examiner
Find more entities like US Patent 8410264 Heterocyclic oxime compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
